Wells Fargo
TCON

Wells Fargo’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-207
Closed -$89 7143
2024
Q1
$89 Buy
207
+3
+1% +$1 ﹤0.01% 6300
2023
Q4
$36 Buy
204
+28
+16% +$5 ﹤0.01% 6581
2023
Q3
$31 Buy
176
+13
+8% +$2 ﹤0.01% 6681
2023
Q2
$47 Sell
163
-61
-27% -$18 ﹤0.01% 6764
2023
Q1
$423 Buy
224
+7
+3% +$13 ﹤0.01% 6276
2022
Q4
$323 Sell
217
-693
-76% -$1.03K ﹤0.01% 6167
2022
Q3
$1K Hold
910
﹤0.01% 6177
2022
Q2
$2K Buy
910
+14
+2% +$31 ﹤0.01% 6104
2022
Q1
$2K Sell
896
-434
-33% -$969 ﹤0.01% 6359
2021
Q4
$3K Hold
1,330
﹤0.01% 6277
2021
Q3
$5K Sell
1,330
-7,429
-85% -$27.9K ﹤0.01% 6064
2021
Q2
$57K Buy
8,759
+3,737
+74% +$24.3K ﹤0.01% 5194
2021
Q1
$42K Sell
5,022
-2,307
-31% -$19.3K ﹤0.01% 5542
2020
Q4
$86K Buy
7,329
+4,575
+166% +$53.7K ﹤0.01% 5242
2020
Q3
$14K Buy
2,754
+956
+53% +$4.86K ﹤0.01% 5527
2020
Q2
$3K Sell
1,798
-8,264
-82% -$13.8K ﹤0.01% 5694
2020
Q1
$17K Buy
10,062
+7,385
+276% +$12.5K ﹤0.01% 5370
2019
Q4
$6K Sell
2,677
-41,743
-94% -$93.6K ﹤0.01% 5646
2019
Q3
$20K Hold
44,420
﹤0.01% 5453
2019
Q2
$30K Buy
44,420
+1,110
+3% +$750 ﹤0.01% 5369
2019
Q1
$59K Buy
43,310
+4,500
+12% +$6.13K ﹤0.01% 5187
2018
Q4
$24K Buy
38,810
+37,529
+2,930% +$23.2K ﹤0.01% 5394
2018
Q3
$3K Hold
1,281
﹤0.01% 5757
2018
Q2
$3K Sell
1,281
-100
-7% -$234 ﹤0.01% 5765
2018
Q1
$3K Sell
1,381
-50
-3% -$109 ﹤0.01% 5729
2017
Q4
$5K Sell
1,431
-7,037
-83% -$24.6K ﹤0.01% 5650
2017
Q3
$27K Buy
8,468
+5,495
+185% +$17.5K ﹤0.01% 5332
2017
Q2
$7K Sell
2,973
-8,959
-75% -$21.1K ﹤0.01% 5498
2017
Q1
$45K Buy
+11,932
New +$45K ﹤0.01% 5182
2016
Q4
Sell
-12,500
Closed -$83K 6013
2016
Q3
$83K Sell
12,500
-2,500
-17% -$16.6K ﹤0.01% 4810
2016
Q2
$66K Sell
15,000
-16,000
-52% -$70.4K ﹤0.01% 4870
2016
Q1
$217K Buy
31,000
+1,679
+6% +$11.8K ﹤0.01% 4234
2015
Q4
$271K Sell
29,321
-6,529
-18% -$60.3K ﹤0.01% 4135
2015
Q3
$350K Buy
35,850
+3,000
+9% +$29.3K ﹤0.01% 4038
2015
Q2
$372K Sell
32,850
-6,350
-16% -$71.9K ﹤0.01% 4163
2015
Q1
$550K Buy
+39,200
New +$550K ﹤0.01% 3810